Celldex Therapeutics
CLDX
#4559
Rank
A$2.63 B
Marketcap
$39.77
Share price
-0.94%
Change (1 day)
-6.10%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -$3.60

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.64. In 2022 the company made an earnings per share (EPS) of -$3.63 a decrease over its 2021 EPS that were of -$2.49.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.60-0.61%
2022-$3.6345.73%
2021-$2.49-23.36%
2020-$3.25-41.05%
2019-$5.51-76.95%
2018-$23.8945.03%
2017-$16.47-42.54%
2016-$28.67-3.82%
2015-$29.81-0.76%
2014-$30.0329.41%
2013-$23.210%
2012-$23.21-9.73%
2011-$25.711312.5%
2010-$1.82-95.79%
2009-$43.19-49.64%
2008-$85.78-82.64%
2007-$494.18-44.98%
2006-$898.251270.83%
2005-$65.5333.33%
2004-$49.14-10%
2003-$54.61-16.67%
2002-$65.53-38.46%
2001-$106.48-4.88%
2000-$111.94-81.66%
1999-$610.21-87.2%
1998-$4,765206.39%
1997-$1,55513.02%
1996-$1,376

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.08 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.29-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-$18.32 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.46-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.82-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.31-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$0.86-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA